Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.

Similar presentations


Presentation on theme: "Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD."— Presentation transcript:

1 Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD

2 Summary Overview of HIV life cycle Overview human immune responses HIV pathogenesis – Acquisition of HIV – Acute infection – Chronic infection and markers of progression – AIDS

3 Overview of HIV life cycle HIV life cycle: 1.Binding and Fusion (let me in!) 2.Reverse transcription (I’m weird) 3.Integration (I am not going anywhere!) 4.Viral RNA and protein expression (Make more viruses!) 5. Assembly and budding (go and infect more cells!) 6. Maturation HIV target cells: CD4T cells, Macrohpages, Dendritic cells

4 Overview of adaptive immunity Nonspecific Specific

5 Overview of adaptive immunity

6 Clearance of viral infection

7 HIV disease progression – clinical latency Levels (Separate Scales) CD4+ T cell HIV viral load CD8+ T cell Neutralizing Antibodies Years AIDS and Death Acute Asymptomatic (clinical latency) 4 – 8 weeks Primary infection

8 HIV disease progression –Acute infection Primary infection of cells in blood or mucosa (HIV directly infects T cells and microphages oris carried to those cells by dendritic cells) Viral replication in the regional lymph nodes leads to Exponential viral growth and widespread dissemination Development of anti-viral responses and symptoms of acute infection occur Decrease in plasma viral load and symptoms of acute infection resolve

9 HIV disease progression -- Clinical Latency During this period of the disease, the immune systems remains competent at handling most infections with opportunistic microbes Few or no clinical manifestation. Steady destruction of CD4+ T cells and steady decline of circulating blood CD4+ T cells

10 Mechanism of CD4 T cell depletion in HIV infection

11 Infection and killing of infected cells only explain part of the T cells loss Chronic immune activation and disrupted T cell homeostasis

12 Stem Cell Mature T-Cells HIV Infected Cells HIV-Specific T Cell Expansion of HIV-Specific Cells Killing of HIV Infected Cells Incomplete Clearance of HIV Infected Cells and Exhaustion HIV Specific T Cell Responses ThymusPeriphery RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT RTRT

13 Virus escapes immune surveillance RTRT Escape Immune pressure

14 T cell exhaustion during persistent infection

15 HIV disease progression -- AIDS Acquired Immune Deficiency Syndrome: Catastrophic breakdown of host defenses, marked increase in viremia and clinical disease. CD4+ cell count less than or equal to 200 per microliter Clinical Features: Opportunistic infection Neoplasms CNS involvement

16 HIV disease progression – clinical latency Levels (Separate Scales) CD4+ T cell HIV viral load CD8+ T cell Neutralizing Antibodies Years AIDS and Death Acute Asymptomatic (clinical latency) 4 – 8 weeks Primary infection

17 Markers of HIV disease progression CD4 T cell counts Viral load Markers of immune activation

18 Markers of disease progression: CD4 cell count Major Factor to initiate therapy – CD4<350: strongly recommended (Data from randomized trials) – <350<CD4<500: strongly recommended (Data from well designed non- redomized trials or observational cohort studies) – Cd4>500: moderately recommended Prophylaxis against opportunistic infection is based on CD4 counts The Lancet Volume 360, Issue 9327 2002 119 - 129

19 Markers of disease progression: Viral load The HIV-1 viral load measurement indicates the number of copies of HIV-1 RNA per milliliter of plasma. Viral load is an accurate reflection of the burden of infection and the magnitude of viral replication. It is critical in monitoring virologic response to ART. The Lancet Volume 360, Issue 9327 2002 119 - 129

20 Markers of disease progression: Viral load set point

21 Chronic immune activation is a characteristic of HIV disease progression. Activation markers expressed on cell surface: CD69, CD25, and MHC class II, CD38, etc. Markers of disease progression: Immune activation markers

22 Questions List key stages for HIV disease progression? While CD4 T cells are progressively depleted during untreated HIV infection, what happens to CD8 T cells? List one important laboratory marker of HIV disease progression other than CD4 cell count

23 Questions List key stages for HIV disease progression? Acute infection, clinical latency, AIDS. While CD4 T cells are progressively depleted during untreated HIV infection, what happens to CD8 T cells? In early HIV infection, CD8 T cells tend to increase in number, in response to viral infection. However, at advanced stages of HIV disease, CD8 cells also decline precipitously. List one important laboratory marker of HIV disease progression other than CD4 cell count Viral load.

24 Discussion How to improve our immunity against HIV?

25 Engineer HIV resistant cells Stem-cell-based gene therapy for HIV infection. Zhen A, Kitchen S1.Zhen A, Kitchen S1. CD4 CCR5 1) Entry 2) Uncoating 3) Reverse transcription 4) Integration CCR5 5) Transcription 7) Translation 8) Assembly 6) RNA export 9) Budding, maturation Rh-hu Trim5a C4 6 Trim5a siRNA/ ribozyme Restriction factors inhibitor C46 ZFN s

26 Broad neutralizing antibodies

27 CD4-Zeta Chimeric Antigen Receptor D1D1 D1D1 D2D2 D2D2 D3D3 D3D3 D4D4 D4D4 CD4-Tm Zeta CD4 TCR  Contains the CD4 molecule extracellular and transmembrane domains,CD3 zeta signaling domain.  Recognizes HIV gp120 independent of HLA restriction.  Ligation induces T cell receptor signaling/activation.  Previously used in peripheral T cells in multiple clinical trials: stable, safe engraftment and persistence >10 years.  Modest clinical efficacy due to functional defects in modified peripheral T cells  Virus unlikely to be able to escape its recognition

28 Stem cell based approach with Protective CD4 chimeric antigen receptor: Summary UbC H1 CCR5 sh1005 CCR5 sh1005 ΔLTR 5’ LTR EGFP CD4-zeta 7SK sh516 2A Ub C H1H1 H1H1 CCR5 sh100 5 CCR5 sh100 5 ΔLT R 5’ LTR EGFP CD4-zeta 7S K sh5 16 2A2A 2A2A CD4 CD3-zeta EGFP RTRT CCR5 HIV HIV siRNA CCR5 siRNA Protected from Infection Pro-inflammatory cytokines CTL Resistant to HIV infection Differentiate into effector cells and expand upon HIV infection Killing of infected T cells HIV infection


Download ppt "Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD."

Similar presentations


Ads by Google